Quality of life, binge eating and sexual function in participants treated for obesity with sustained release naltrexone/bupropion

OBJECTIVE: This multicenter, randomized, controlled, open‐label trial examined weight‐related quality of life, control over eating behaviour and sexual function after 26 weeks of treatment with either 32 mg naltrexone sustained release (SR)/360 mg bupropion SR plus a comprehensive lifestyle interven...

Full description

Saved in:
Bibliographic Details
Published in:Obes Sci Pract
Main Authors: Halseth, A., Shan, K., Gilder, K., Malone, M., Acevedo, L., Fujioka, K.
Format: Artigo
Language:Inglês
Published: John Wiley and Sons Inc. 2018
Subjects:
Original Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5893468/
https://ncbi.nlm.nih.gov/pubmed/29670752
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/osp4.156
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items